top of page
ARTICLES
Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.
Managing Partner, Harris Kaplan, published in BioSpace: Why KOL Enthusiasm Often Doesn’t Predict Commercial Success
KOL enthusiasm can signal early promise, but it rarely tells the full story. Harris Kaplan examines why expert advocacy often fails to translate into market adoption—and what life sciences teams should evaluate instead.
Apr 221 min read
Managing Partner, Harris Kaplan, published in PharmExec: Your Phase III Clinical Protocol Is Your Initial Product Launch
Phase III clinical protocols do more than satisfy regulators. They determine what a product can claim, how it will be valued, and whether it can truly compete at launch.
Jan 301 min read
Managing Partner, Harris Kaplan, published in Forbes: Biotech Investing - Is Hope Fueling Hype?
Harris Kaplan , Managing Partner, just published an article in Forbes, Biotech Investing: Is Hope Fueling Hype? . Hope is a major reason...
Oct 28, 20211 min read
Managing Partner, Harris Kaplan, published in Forbes: The Importance Of Being An Optimistic Realist In Biotech Investing
Harris Kaplan , Managing Partner, just published an article in Forbes, The Importance Of Being An Optimistic Realist In Biotech...
Jul 13, 20211 min read
Managing Partner, Harris Kaplan, published in Forbes: All That Glitters Isn't Gold: Questions To Ask
Harris Kaplan , Managing Partner, just published an article in Forbes, All That Glitters Isn't Gold: Questions To Ask Yourself Before...
Mar 10, 20211 min read
Managing Partner, Harris Kaplan, published in PharmExec: Marketers - Physicians are People First
Harris Kaplan , Managing Partner, just published an article in PharmExec (titled Marketers: Physicians are People First ) that looks at...
Nov 17, 20201 min read
bottom of page